1: Petrillo P, Gambino MC, Tavani A. Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats. Life Sci. 1984 Aug 27;35(9):917-27. PubMed PMID: 6381949.
2: Simonin F, Slowe S, Becker JA, Matthes HW, Filliol D, Chluba J, Kitchen I, Kieffer BL. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice. Eur J Pharmacol. 2001 Mar 2;414(2-3):189-95. PubMed PMID: 11239918.
3: Dortch-Carnes J, Potter DE. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005 Summer;11(2):195-212. Review. PubMed PMID: 16007240.
4: Shearman GT, Stenfors C. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors. Pharmacol Biochem Behav. 1986 Apr;24(4):861-3. PubMed PMID: 3012599.
5: Cosgrove KP, Carroll ME. Differential effects of bremazocine on oral phencyclidine (PCP) self-administration in male and female rhesus monkeys. Exp Clin Psychopharmacol. 2004 May;12(2):111-7. PubMed PMID: 15122955.
6: Castellano C, Pavone F. Effects of bremazocine on passive avoidance behaviour
in mice. Arch Int Pharmacodyn Ther. 1986 Oct;283(2):199-208. PubMed PMID: 3789883.
7: Nestby P, Schoffelmeer AN, Homberg JR, Wardeh G, De Vries TJ, Mulder AH, Vanderschuren LJ. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference. Psychopharmacology (Berl). 1999 Mar;142(3):309-17. PubMed PMID: 10208324.
8: Russell KR, Wang DR, Potter DE. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res. 2000 May;70(5):675-82. PubMed PMID: 10870526.
9: Bianchi G. Antidiuretic effect of bremazocine and U-50,488 in rats after alpha 2-adrenoceptor blockade. J Pharm Pharmacol. 1991 Mar;43(3):212-6. PubMed PMID: 1675283.
10: Freye E, Hartung E, Schenk GK. Bremazocine: an opiate that induces sedation and analgesia without respiratory depression. Anesth Analg. 1983 May;62(5):483-8. PubMed PMID: 6301311.
11: Amarante LH, Duarte ID. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway. Eur J Pharmacol. 2002 Nov 1;454(1):19-23. PubMed PMID: 12409000.
12: Potter DE, Russell KR, Manhiani M. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May;309(2):548-53. Epub 2004 Jan 23. PubMed PMID: 14742737.
13: Vanderschuren LJ, Schoffelmeer AN, Wardeh G, De Vries TJ. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine
and cocaine. Psychopharmacology (Berl). 2000 May;150(1):35-44. PubMed PMID: 10867974.
14: Horan PJ, de Costa BR, Rice K, Haaseth RC, Hruby VJ, Porreca F. Differential
antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse. J Pharmacol Exp Ther. 1993 Aug;266(2):926-33. PubMed PMID: 8394923.
15: Negus SS, Morgan D, Cook CD, Picker MJ. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a
three-choice drug discrimination procedure. Psychopharmacology (Berl). 1996 Aug;126(3):199-205. PubMed PMID: 8876019.
16: Horan P, de Costa BR, Rice KC, Porreca F. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice. J Pharmacol Exp Ther. 1991 Jun;257(3):1154-61. PubMed PMID: 1646325.
17: Castellano C, Pavone F. Effects of bremazocine on locomotor activity in DBA/2 and C57BL/6 mice. Arch Int Pharmacodyn Ther. 1985 Nov;278(1):45-52. PubMed PMID:
4096608.
18: Amarante LH, Alves DP, Duarte ID. Study of the involvement of K+ channels in
the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
Eur J Pharmacol. 2004 Jun 28;494(2-3):155-60. PubMed PMID: 15212969.
19: Rasmussen CA, Gabelt BT, Kaufman PL. Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine. Trans Am Ophthalmol Soc. 2007;105:225-38; discussion 238-9. PubMed PMID: 18427613; PubMed Central PMCID: PMC2258115.
20: Li Q, Kim SK, Goddard WA 3rd, Chen G, Tan H. Predicted structures for kappa opioid G-protein coupled receptor bound to selective agonists. J Chem Inf Model.
2015 Mar 23;55(3):614-27. doi: 10.1021/ci500523z. Epub 2015 Feb 17. PubMed PMID:
25642595.